Videos Health Innovators – Jo Brewer, Adaptimmune In this episode of Health Innovators, pharmaphorum founder Paul Tunnah interviews Jo Brewer, senior vice president of allogeneic res
Views & Analysis Deep Dive: Oncology 2021 This has probably been the toughest year for oncology researchers in memory.
Views & Analysis Changing focus to cachexia may be key to improved cancer out... Cachexia could be the next blockbuster area in cancer therapeutics because of its link to survival outcomes. Physician and researcher Dr.
Views & Analysis The next generation of immunotherapy? Innate Pharma targets ... Clinical-stage oncology biotech Innate Pharma is on a mission to harness the power of natural killer cells to fight cancer.
Events Partner Content Triple Negative Breast Cancer Drug Development Digital Summi... Fast-track the Discovery & Development of TNBC
News Pfizer deal paves way for approval of ImaginAb's cancer imag... ImaginAb has signed a deal with Pfizer, which it hopes will help it to gather information necessary for approval of its tumour imaging agent as a medical device in markets in the US and oth
Oncology On looking to a future multiomics approach for CDx, with Jan... The pharmaphorum podcast caught up with Jane Li, VP and general manager for companion diagnostics at Thermo Fisher Scientific, following ESMO 2026.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.